Navigation Links
The AGA Foundation awards grant to Dr. Michael Choi to further his research on carcinoid tumors
Date:6/25/2009

Bethesda, MD (June 25, 2009) The AGA Foundation for Digestive Health and Nutrition (FDHN) has named Michael Y. Choi , MD, the first recipient of the Mary Terese Hartzheim Award for Neuroendocrine Tumor Research. This new research award was created for young investigators interested in researching carcinoid or neuroendocrine tumors. Dr. Choi is an investigator at Massachusetts General Hospital and an instructor of medicine at Harvard Medical School, Boston. He was previously named an AGA Foundation Research Scholar Award recipient in 2005.

"We are pleased to be working with the Mary Terese Hartzheim (MTH) Foundation and Caring for Carcinoid Foundation (CFCF) to fund this grant for individuals who show promise in researching the development, diagnosis and treatment of carcinoid and neuroendocrine tumors," said Sidney Cohen, MD, AGAF, chairman of the Foundation for Digestive Health and Nutrition. "The AGA Foundation for Digestive Health and Nutrition helps fund gifted scholars to enable them to begin and/or maintain their research programs. We are especially pleased when previous grant recipients continue their work and qualify for additional funding to further their research."

The five-year survival rate for intestinal carcinoids in the U.S. between 1973 and 2002 has remained at 60 percent. This lack of improvement in treatment success is largely due to incomplete understanding of the biology behind both neuroendocrine tumors and the corresponding neuroendocrine cells. Carcinoid tumors are rare, slow-growing cancers that usually start in the lining of the digestive tract or in the lungs. Because they grow slowly and often do not produce symptoms in the early stages, the average age of people diagnosed with digestive or lung carcinoids is about 60. Surgery is the main treatment for carcinoid tumors; if they haven't spread to other parts of the body, surgery can cure the cancer.

The Mary Terese Hartzheim Award for Neuroendocrine Tumor Research provides $75,000 per year for two years (total $150,000) to a junior investigator who will make meaningful contributions to understanding the biology of carcinoid and neuroendocrine tumors and/or the development of novel therapeutic approaches to this group of diseases. The award's objective is to expand interest and expertise in this specific field of research at academic medical institutions, and to attract new scientists who may not have previously worked in this area.


'/>"/>

Contact: Aimee Frank
media@gastro.org
301-941-2620
American Gastroenterological Association
Source:Eurekalert

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... June 24, 2016 Research and Markets ... for Companion Diagnostic Tests" report to their offering. ... Companion Diagnostics The World Market for Companion ... medicine diagnostics. Market analysis in the report includes the following: ... (In Vitro Diagnostic Kits) by Region (N. America, EU, ROW), ...
(Date:6/24/2016)... , June 24, 2016 VolitionRx ... of Dr. Edward Futcher to the ... effective June 23, 2016.Dr. Futcher was also appointed ... Governance Committees.  As a non-executive member of the ... and strategic counsel to VolitionRx in connection with ...
Breaking Medicine Technology: